PT-141 Melanotan-2 Protocol Central + Peripheral Effects Research published in the Journal of Sexual Medicine found that PT-141 (bremelanotide) increased female sexual desire scores by 37% compared to baseline through c…
PT-141 & Melanotan-2: Central vs Peripheral Effects A 2019 Phase 3 trial published in JAMA Internal Medicine found that bremelanotide (PT-141) produced statistically significant improvements in desire and arousal in pre…
Stacking PT-141 + Melanotan-2 — Central vs Peripheral Most peptide stacks fail because users assume different mechanisms equal synergy. PT-141 (bremelanotide) and Melanotan-2 both activate melanocortin receptors. The sa…